Q4 2005 Andrx Corporation Earnings Conference Call - Research and Markets Offers a Transcript of 'Andrx Corporation' Conference Call.DUBLIN, Ireland -- The Andrx Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ADRX ADRX Andrx Corporation (stock symbol) ) Corporate Conference Call took place on 17-Mar-06 8:00am ET. The Co. reported that in 2005, total revenues for the second year in a row exceeded $1b, with $1b in 2005 vs. $1.1b in 2004. 2005 diluted EPS (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format. was $0.85 vs. $0.89 in 2004. During 4Q05, the Co. generated total revenues of $245m, a 16% decrease vs. 4Q04. Diluted EPS was $0.11 in 4Q05. Earlier this week, the Co. announced the signing of a definitive merger agreement providing for the acquisition of ADRX by Watson Pharmaceuticals Watson Pharmaceuticals, Incorporated (NYSE: WPI) is the 5th largest pharmaceutical company in the United States based on number of prescriptions dispensed. Based in Corona, California, Watson's Generics division markets over 150 pharmaceutical product families, including one of the . More information on this Conference Call can be obtained from Research and Markets at http://www.researchandmarkets.com/transcripts/83222 This document provides verbatim text of the conference call. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion